Latest Articles
Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer? - Pharmacy Times
Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer? Pharmacy Times
Published: May 22, 2026, 4:29 a.m.
Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer, Full Data Due at ASCO 2026 - OncLive
Dostarlimab Combo Shows Durable Disease Control in dMMR/MSI-H Endometrial Cancer, Full Data Due at ASCO 2026 OncLive
Published: May 22, 2026, 3:43 a.m.
Research Suggests Powerful Cancer Prevention Combo: GLP-1RAs and Progestins for Women at Risk - Medical Dialogues
Research Suggests Powerful Cancer Prevention Combo: GLP-1RAs and Progestins for Women at Risk Medical Dialogues
Published: May 22, 2026, 12:30 a.m.
Acrivon Therapeutics’ SWOT analysis: stock shows promise in cancer pipeline - Investing.com UK
Acrivon Therapeutics’ SWOT analysis: stock shows promise in cancer pipeline Investing.com UK
Published: May 21, 2026, 8:34 p.m.
Samie Johnson shares her rare cancer diagnosis - Now to Love NZ
Samie Johnson shares her rare cancer diagnosis Now to Love NZ
Published: May 21, 2026, 8:30 p.m.
ASCO 2026: Previewing Cervical and Endometrial Cancer Data - Medscape
ASCO 2026: Previewing Cervical and Endometrial Cancer Data Medscape
Published: May 21, 2026, 8:28 p.m.
Endometrial Cancer: Why The Patient’s Voice Needs To Be Part Of The Treatment Plan - SurvivorNet
Endometrial Cancer: Why The Patient’s Voice Needs To Be Part Of The Treatment Plan SurvivorNet
Published: May 21, 2026, 8:02 p.m.
Potential Immunotherapy After Immunotherapy in Select Endometrial Cancer Populations - CancerNetwork
Potential Immunotherapy After Immunotherapy in Select Endometrial Cancer Populations CancerNetwork
Published: May 21, 2026, 7 p.m.
'New cancer test makes me feel women's health matters' - MSN
'New cancer test makes me feel women's health matters' MSN
Published: May 21, 2026, 4:27 p.m.
Acrivon Therapeutics’ SWOT analysis: stock shows promise in cancer pipeline - Investing.com
Acrivon Therapeutics’ SWOT analysis: stock shows promise in cancer pipeline Investing.com
Published: May 21, 2026, 2:57 p.m.
Link copied to clipboard!